Johnson & Johnson Terminate Phase III VENTURA Program for Aticaprant in adjunctive treatment of MDD
CompanyDrug

Johnson & Johnson Terminate Phase III VENTURA Program for Aticaprant in adjunctive treatment of MDD

Gan & Lee Pharmaceuticals Joins Brazil's PDP for Localized Insulin Production
CompanyDrug

Gan & Lee Pharmaceuticals Joins Brazil’s PDP for Localized Insulin Production

Insilico Medicine's AI-Discovered Drug Rentosertib Approved for Clinical Trials
CompanyDrug

Insilico Medicine’s AI-Discovered Drug Rentosertib Approved for Clinical Trials

4C Medical Lands $175M Series D to Advance AltaValve TMVR System
CompanyDeals

4C Medical Lands $175M Series D to Advance AltaValve TMVR System

Merck KGaA Reports 2024 Revenue Growth Despite Challenges in Life Sciences
Company

Merck KGaA Reports 2024 Revenue Growth Despite Challenges in Life Sciences

Astellas Pharma and YASKAWA Establish JV for Cell Therapy Product Manufacturing Platform
CompanyDeals

Astellas Pharma and YASKAWA Establish JV for Cell Therapy Product Manufacturing Platform

Johnson & Johnson Officially Launches Spravato in China for Depression Treatment
CompanyDrug

Johnson & Johnson Officially Launches Spravato in China for Depression Treatment

Abbisko Therapeutics' ABSK131 Receives Clinical Trial Approval from China's NMPA
CompanyDrug

Abbisko Therapeutics’ ABSK131 Receives Clinical Trial Approval from China’s NMPA

Cryofocus Biotechnology's Malignant Stenosis Cryoablation System Approved by NMPA for Chinese Market
CompanyMedical Device

Cryofocus Medtech’s Malignant Stenosis Cryoablation System Approved by NMPA for Chinese Market

Roche and JD Healthcare Collaborate on Influenza Prevention with Xofluza (Baloxavir Marboxil)
CompanyDeals

Roche and JD Healthcare Collaborate on Influenza Prevention with Xofluza (Baloxavir Marboxil)

Suzhou GenAssist's GEN6050X Receives FDA Clearance for Duchenne Muscular Dystrophy Treatment
CompanyDrug

Suzhou GenAssist’s GEN6050X Receives FDA Clearance for Duchenne Muscular Dystrophy Treatment

BioRay Biopharmaceutical's BR111 Receives NMPA Clearance for Clinical Trials in ROR1-Positive Malignancies
CompanyDrug

BioRay Biopharmaceutical’s BR111 Receives NMPA Clearance for Clinical Trials in ROR1-Positive Malignancies